Viking Therapeutics Inc (NASDAQ: VKTX): Stock Forecast For 2024 Remains Weak With A Downward Revision Of 35.3%
In the latest trading session, 1.13 million shares of the Viking Therapeutics Inc (NASDAQ:VKTX) were traded, and its beta was 1.01. Most recently the company’s